INTRODUCTION {#s1}
============

Hip fracture is a fracture of the upper part of the femur, and has high incidence in the elderly \[[@R1]\]. Hip fractures in aged people leads to high mortality, high risk of postoperative complication, and impaired quality of life \[[@R2]--[@R5]\]. The mortality is increased from 8.4% to 36% in the first postoperative year \[[@R6]\].

The risk factors for mortality following hip fracture surgery was demonstrated in some studies \[[@R7]\], we hope to reveal the clinically relevant biomarkers to evaluate prognosis and complication events. It has been reported that serum albumin level and lymphocyte count served as an independent prognostic factor in hip fracture patients \[[@R8]\]. The prognostic nutritional index (PNI) is calculated by the serum albumin concentration and the peripheral blood lymphocyte count \[[@R9]\]. Albumin is an indicator of nutritional status which is correlated with post-operative complications \[[@R10]\]. The PNI can be used to assess the immunological and nutritional status of surgery patients \[[@R11]\], and estimated according to the following formula: 10 × serum albumin (g/dL) + 0.05 total lymphocyte count (/mm^3^) \[[@R12]\]. C-reactive protein (CRP) is an inflammatory marker which is closely related to the infections and outcomes in orthopaedics \[[@R13]\]. And PNI is associated with cancer mortality and has a prognostic value \[[@R14]\].

The correlation of CRP/PNI ratio and mortality after hip fracture surgery, especially in elderly population remains unknown. This study is aim to evaluate the predictive value of CRP/PNI ratio in elderly patients after orthopedic surgery, and compare it with clinical variables.

RESULTS {#s2}
=======

We estimated the CRP/PNI ratio in 80 patients, 35 (43.75%) of whom were men and 45 (56.25%) were women. The results are presented in Figure [1](#F1){ref-type="fig"} and summarized in Table [1](#T1){ref-type="table"}; the mean CRP and PNI were 11.3 ± 9.6 mg/L and 41.3 ± 11.0, respectively. An inverse correlation was found between CRP and PNI with a correlation coefficient of -0.761 which was shown in Figure [1](#F1){ref-type="fig"} (*P* =0.016). The relationships between the CRP/PNI ratio and clinical characteristics were shown in Table [1](#T1){ref-type="table"}. Based on the receiver operating characteristics (ROC) analyses, the best cut-off value of CRP/PNI ratio was 0.10. Then, patients were divided into two groups: patients with CRP/PNI ratio ≤0.10 and patients with CRP/PNI ratio \>0.10. There were 42 (52.5%) patients with CRP/PNI ratio ≤0.10 and 38 (47.5%) patients with CRP/PNI ratio \>0.10. CRP/PNI ratio is correlated significantly with CRP (*P* \<0.001), leukocytosis (*P* =0.003), lymphocyte counts (*P* \<0.001), hypoalbuminemia (*P* =0.001), PNI (*P* \<0.001) and survival (*P* \<0.001), but no relationships were found between CRP/PNI ratio and other factors such as comorbidity, platelet count and anemia.

![Pearson correlation\
A signifcant negative correlation between CRP and PNI (r=-0.761, *P* =0.016). CRP: C-reactive protein; PNI: prognostic nutritional index.](oncotarget-08-61365-g001){#F1}

###### The CRP/PNI ratio and clinicopathological parameters

                              Case(n)          CRP/PNI ratio    *p* Value        
  --------------------------- ---------------- ---------------- ---------------- ---------
  Age (years)                 86±5             85±7             87±3             0.192
  Men                         35               18               17               0.301
  Weight (kg)                 62 (49--78)      61 (45--74)      63 (55--78)      0.762
  Length of stay (day)        7 (5--14)        6 (5--10)        9 (6--14)        0.162
  Duration of surgery (min)   140 (111--170)   140 (111--170)   140 (111--170)   0.912
  Comorbidity                                                                    
   Diabetes mellitus          34               17               17               0.684
   Cardiovascular disease     24               13               11               0.726
   Hypertension               63               32               31               0.710
   Renal disefficiency        21               12               9                0.691
  CRP, mg/L                                                                      
   \<10                       43               39               4                0.000\*
   ≥10                        36               2                34               
  Platelet count,/mm3                                                            
   \<214                      43               18               25               0.067
   ≥214                       37               24               13               
  Leukocytosis                                                                   
   Yes                        26               9                17               0.033\*
   No                         54               33               21               
  Anemia                                                                         
   Yes                        42               25               17               0.262
   No                         38               17               21               
  Lymphocyte counts,/mm3                                                         
   \<1673                     43               31               12               0.000\*
   ≥1673                      37               11               26               
  Hypoalbuminemia                                                                
   Yes                        28               26               2                0.001\*
   No                         52               16               36               
  PNI                                                                            
   \<44                       39               1                38               0.000\*
   ≥44                        41               41               0                
  Survival status                                                                
   Dead                       41               3                38               0.000\*
   Alive                      39               39               0                

CRP: C-reactive protein; PNI: prognostic nutritional index; \* *P*\<0.05 is considered significant.

Concerning survival, only 3 of 42 (7.1 %) patients in the CRP/PNI ratio ≤0.10 group died versus 38 of 38 (100.0 %) in the CRP/PNI ratio \>0.10 group (Table [2](#T2){ref-type="table"}). The survival was significantly influenced by only CRP (*P* \<0.001), lymphocyte counts (*P* =0.013), hypoalbuminemia (*P* =0.002), PNI (*P* \<0.001) and CRP/PNI ratio (*P* \<0.001), while all variables were compared separately to survival status (Table [2](#T2){ref-type="table"}). In univariate analysis, the Kaplan--Meier survival curves showed to no significant relationship between platelet count, leukocytosis, anemia and survival. The Kaplan--Meier survival curves of low CRP/PNI ratio versus high CRP/PNI ratio showed a highly significant separation (*P* \<0.001, Figure [2C](#F2){ref-type="fig"}). Furthermore, patients with high CRP (*P* \<0.001, Figure [2A](#F2){ref-type="fig"}) or low PNI (*P* \<0.001, Figure [2B](#F2){ref-type="fig"}) were also related to the poor 1-year survival, respectively. When a multivariate Cox proportional hazard model was constructed (including age, duration of surgery, weight, length of stay, sex, CRP, PNI, platelet count, leukocytosis, anemia, lymphocyte counts, hypoalbuminemia and CRP/PNI ratio), the CRP/PNI ratio was the strongest independent predictor of survival (Table [3](#T3){ref-type="table"}).

###### Survival status and clinicopathological parameters in 80 specimens

                              Case(n)          Survival status   *p* Value        
  --------------------------- ---------------- ----------------- ---------------- ---------
  Age (years)                 86±5             87±5              85±4             0.059
  Men                         35               19                16               0.142
  Weight (kg)                 62 (49--78)      60 (49--72)       63 (50--78)      0.699
  Length of stay (day)        7 (5--14)        8 (6--14)         7 (5--12)        0.734
  Duration of surgery (min)   140 (111--177)   146 (112--177)    139 (111--168)   0.209
  Comorbidity                                                                     
   Diabetes mellitus          34               20                14               0.550
   Cardiovascular disease     24               13                11               0.673
   Hypertension               63               33                30               0.897
   Renal disefficiency        21               11                10               0.803
  CRP, mg/L                                                                       
   \<10                       43               7                 36               0.000\*
   ≥10                        36               34                2                
  Platelet count,/mm3                                                             
   \<214                      43               26                17               0.116
   ≥214                       37               15                22               
  Leukocytosis                                                                    
   Yes                        26               17                9                0.098
   No                         54               24                30               
  Anemia                                                                          
   Yes                        42               18                24               0.125
   No                         38               23                15               
  Lymphocyte counts,/mm3                                                          
   \<1673                     43               13                30               0.013\*
   ≥1673                      37               28                9                
  Hypoalbuminemia                                                                 
   Yes                        28               26                2                0.002\*
   No                         52               15                37               
  PNI                                                                             
   \<44                       39               39                0                0.000\*
   ≥44                        42               2                 30               
  CRP/PNI                                                                         
   ≤ 0.10                     42               3                 39               0.000\*
   \> 0.10                    38               38                0                

CRP: C-reactive protein; PNI: prognostic nutritional index; \* *P*\<0.05 is considered significant.

![Kaplan-Meier survival curves stratifed by CPR, PNI and CRP/PNI ratio\
**(A and B)** Patients with elevated CRP (*P* \<0.001) or decreased PNI (*P* \<0.001) were associated with decreased 1-year survival, respectively. **(C)** Patients with CRP/PNI ratio ≤0.10 had a better 1-year survival than patients with CRP/PNI ratio \>0.10 (*P* \<0.001). CRP: C-reactive protein; PNI: prognostic nutritional index.](oncotarget-08-61365-g002){#F2}

###### Contribution of various potential prognostic factors to survival by Cox regression analysis in 80 specimens

                              Hazard ratio   95 % CI        *P*
  --------------------------- -------------- -------------- ---------
  Age(years)                  1.5            0.775∼2.430    0.158
  Duration of surgery (min)   0.7            0.341∼3.776    0.342
  Weight (kg)                 1.8            0.656∼3.167    0.782
  Length of stay (day)        0.2            0.096∼2.034    0.053
  Sex                         1.9            0.127∼3.907    0.102
  CRP, mg/L                   3.3            1.337∼8.737    0.054
  PNI                         0.2            0.028∼0.650    0.067
  Platelet count,/mm3         2.0            0.672∼6.101    0.210
  Leukocytosis                0.9            0.313∼2.860    0.922
  Anemia                      1\. 3          0.432∼3.811    0.653
  Lymphocyte counts,/mm3      2.1            1.093∼6.107    0.059
  Hypoalbuminemia             1.4            0.897∼3.357    0.072
  CRP/PNI                     8.1            1.806∼36.216   0.006\*

CRP: C-reactive protein; PNI: prognostic nutritional index; CI: confidence interval; statistical analyses were performed by the log-rank test; \* *P*\<0.05 is considered significant.

The areas under the curve (AUC) was 0.998 for CRP/PNI ratio (95% CI: 0.000-1.000, *P* \<0.001), 0.928 (95% CI: 0.861-0.990, *P* \<0.001) for CRP and 0.953 (95% CI: 0.002-0.996, *P* \<0.001) for PNI. Our results indicated that the CRP/PNI ratio was superior to the CRP or PNI (Figure [3](#F3){ref-type="fig"}) for the older patients after hip fracture surgery.

![Comparison of the AUC for ROC curves\
The AUC of the CRP/PNI ratio was higher than other CRP or PNI, indicating that the CRP/PNI ratio was superior to the CRP or PNI for prognosis. CRP: C-reactive protein; PNI: prognostic nutritional index; AUC: area under curve; ROC: receiver operating characteristics.](oncotarget-08-61365-g003){#F3}

DISCUSSION {#s3}
==========

Because of the poor prognosis of acute surgery in elderly patients, biomarkers in clinical management of these patients are important. In our study, CRP/PNI ratio was used as an independent prognostic factor for elderly patients after orthopedic surgery. And this is the first study which examined the prognostic value of CRP/PNI ratio for elderly patients after orthopedic surgery.

Infection or traumas has a strong relationship with inflammation. Previous data have shown that CRP is a sensitive and non-specific inflammatory marker of human infection or traumas \[[@R15]\]. CRP is proved to be very useful in diagnosis and functioned as a monitor of infections in orthopaedics \[[@R13]\]. A retrospective analysis conducted by Kim et al. \[[@R15]\] revealed that preoperative CRP was an independent risk factor for 1-year mortality after hip fracture surgery in the elderly. In our current research, these patients with low CRP levels (≤10.0 mg/L) had better survival than those with CRP \>10.0 mg/L (83.7% vs. 5.6%, *P* \<0.001). Regrettably, in the multivariate analyses, there was no evidence to prove that CRP was an independent prognostic factor (*P* =0.054).

The PNI was designed to assess the immunologic and nutritional aspects of surgical patients \[[@R16]\], and calculated by the serum albumin concentration and the lymphocyte count in the peripheral blood \[[@R17]\]. Hypoalbuminemia served as a potential preoperative predictor of outcomes \[[@R18]\]. Lu et al. showed that a lower serum albumin level and total lymphocyte count were important risk factors to predict the one-year mortality of elderly patients with fracture \[[@R19]\]. However, few studies focused on PNI in elderly patients after hip fracture surgery. In our data, PNI was not an independent prognostic factor (*P* =0.067).

As CRP and PNI are affected by various conditions, the CRP/PNI ratio could therefore reduce the potential bias. The prognostic value of CRP/PNI ratio is better than CRP or PNI in elderly patients after hip fracture surgery. In this study, the CRP/PNI ratio has been investigated to assess the outcomes of the elderly patients after hip fracture surgery. Patients with low CRP/PNI ratio had a longer median survival time than those with high CRP/PNI ratio (88.6% vs. 0%, *P* \<0.001). CRP/PNI ratio has been demonstrated as an important predictive factor of 1-year survival by multivariate analyses (*P*=0.006). The CRP/PNI ratio had not been investigated before in hip fracture surgery patients before, especially in elderly patients. This is the first time to elucidate that CRP/PNI ratio is a predictor of hip fracture surgery in elderly patients.

In our Cox regression model, multivariate analyses revealed that the CRP/PNI ratio was an independent prognostic factor. Our data showed that the AUC was higher in CRP/PNI ratio than CRP (0.928) or PNI (0.963) by ROC analyses. High levels of CRP/PNI ratio could help us to avoid adverse consequences. Patients will benefit from the CRP/PNI ratio, especially in the elderly patients.

Nevertheless, several limitations should be paid attention in this study. Firstly, this study is a retrospective and single-institution study. Secondly, the number of patients was not adequate (n =80). Thence, larger prospective studies need to be carried out to confirm these preliminary results.

In summary, current data indicate that CRP/PNI ratio is correlated with 1-year survival in elderly patients after hip fracture surgery. Based on these results, we believe that CRP/PNI ratio is a novel and useful predictive factor in elderly patients after hip fracture surgery.

MATERIALS AND METHODS {#s4}
=====================

Patients {#s4_1}
--------

The data of 80 elderly patients after hip fracture surgery in Shanghai Pudong Hospital between 2015 and 2016 were collected in our study. The 70 years of age or older patients were included, and the patients were excluded if CRP, platelet count, leukocyte count, lymphocyte counts, hemoglobin and albumin measurements were lacking. Ethical approval was obtained for the study protocols and informed consents were obtained from each patient.

Data collection {#s4_2}
---------------

We collected clinical data including age, sex, weight, length of stay, duration of surgery, comorbidity, biological data and survival time. The patients had been tested for serum CRP, platelet count, leukocyte count, lymphocyte counts, hemoglobin and albumin before surgery. At the same time, we carefully reviewed the associated comorbidities of these patients. The biological data were measured by automatic laser nephelometry (BN 100 analyzer, Germany). The normal values of CRP, platelet count, leukocyte count, lymphocyte counts, hemoglobin and albumin were 0--10 mg/L, 125--350 ×10^9^/L, 3.5--9.5×10^9^/L, 1.1--3.2 ×10^9^/L, 110--175 ×10^9^/L, 35--50 g/L, respectively.

Follow-up and endpoint {#s4_3}
----------------------

The mean follow-up period for these patients was 8.7 months (range: 3--12 months). All patients were followed up by phone monthly. The endpoint was mortality within one year.

Statistical analysis {#s4_4}
--------------------

All statistical analyses were used the SPSS version 22.0 statistical software. The association between CRP and PNI were studied using the Spearman rank correlation test Survival analysis. For analysis of survival data, Kaplan-Meier curves were constructed, and the log-rank test was used for analysis. Univariate and multivariate analyses were performed using Cox's proportional hazards model. Differenceswere considered statistically significant when P value was less than 0.05.
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